Showing 9471-9480 of 20372 results for "".
- Researchers Unravel Glucose-Sensing Mechanism That Controls Thermogenesishttps://reachmd.com/news/researchers-unravel-glucose-sensing-mechanism-that-controls-thermogenesis/2462670/Adipocytes, also known as fat cells, come in three main types: white, brown, and beige. White fat cells are structurally quite simple, comprising a single fat molecule and a few organelles. The function of white adipocytes is to store energy, in
- For a Healthy Fruit Snack, What Would You Choose?https://reachmd.com/news/for-a-healthy-fruit-snack-what-would-you-choose/2457460/Next time you're packing lunch for your kid or reaching for a healthy afternoon bite, consider this: only three types of fruit snacks -- dried fruit, fruit puree and canned fruit with juice -- meet the latest recommendations for high-nutrition snacks set by federal dietary guidelines, accord
- Penn’s Kidney Transplant Program Has Set a World Record for Most ‘Paired Donations’ in a Yearhttps://reachmd.com/news/penns-kidney-transplant-program-has-set-a-world-record-for-most-paired-donations-in-a-year/2456752/When Rich Green learned that he needed a new kidney last fall, several of his friends and family members stepped forward as potential donors. But none were an exact match.Patients who need transplanted organs must receive them from someone whose blood type and tissu
- Exploring GLP-1 Receptor Agonists: Weight Loss Efficacy and Ocular Safetyhttps://reachmd.com/news/exploring-glp-1-receptor-agonists-weight-loss-efficacy-and-ocular-safety/2482959/GLP-1 Receptor Agonists transform diabetes and obesity treatment landscapes, but balancing efficacy with safety remains a clinical challenge, as suggested by a large observational a
- Dr. Karan Lal Shares 'Recipe' for Prescribing GLP-1shttps://reachmd.com/news/dr-karan-lal-shares-recipe-for-prescribing-glp-1s/2483869/The increasingly understood relevance of weight-loss drugs to inflammatory skin conditions was a hot topic at the Skin of Color Update in New York, New York, and Karan Lal, DO, FAAD, shared his “recipe” for addressing it with patients. Dr. Lal first checks for prior diagnoses of diabetes m
- Hidradenitis Suppurativa Genetics Linked to Cardiometabolic Riskhttps://reachmd.com/news/hidradenitis-suppurativa-genetics-linked-to-cardiometabolic-risk/2471117/A high polygenic risk score (PRS) for hidradenitis suppurativa (HS) is linked to an increased risk of coronary artery disease (CAD) and diabetes, according to a new analysis of UK Biobank data. Study researchers included 391,481 individuals of European ancestry with data in UK Biobank in t
- Op-Ed: 10 Early Lessons that Shaped My Money Philosophyhttps://reachmd.com/news/op-ed-10-early-lessons-that-shaped-my-money-philosophy/2457400/We all learned things about money growing up, whether intentionally or not. Does what we learned in childhood matter to our financial lives once we come of age? Raised by an ultra-frugal dad and a joyful spender of a mom, I appreciate what I’ve learned from each approach. Here are ten earl
- AI Foundation Models Reshape Ophthalmic Diagnosishttps://reachmd.com/news/ai-foundation-models-reshape-ophthalmic-diagnosis/2487186/Key Takeaways The review covered vision and vision-language foundation models in ophthalmology, with retinal disease diagnosis as the most common application area. Strong performance was reported across diabetic retinopathy, age-related macular degener
- Mounjaro: A Paradigm Shift in Sleep Apnea Managementhttps://reachmd.com/news/mounjaro-a-paradigm-shift-in-sleep-apnea-management/2475151/Currently, Mounjaro is not approved by Australia's Therapeutic Goods Administration specifically for sleep apnea; it remains focused on diabetes and weight management. Obstructive sleep apnea remains heavily managed by continuous posit
- Semaglutide: Cardiovascular Protection in High-Risk Obesityhttps://reachmd.com/news/semaglutide-cardiovascular-protection-in-high-risk-obesity/2474611/The SELECT trial provides compelling evidence that semaglutide offers early cardiovascular protection in overweight or obese patients with pre-existing heart disease, even without the presence of diabetes. These findings highlight semaglutide's